Company: AIP
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001667011-25-000029
Chunk: 265

Company: Arteris, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 265
---
 for unrecognized tax benefits was $3.6 million and $3.5 million, respectively. The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of June 30, 2025 and 2024, the Company had immaterial accrued interest or penalties related to its unrecognized tax benefits. If any unrecognized tax benefits are realized, it would not result in any income tax benefit as the Company currently has a full valuation allowance against the deferred tax assets in which there is currently an uncertain tax benefit. On July 4, 2025, President Trump signed H.R. 1, the One Big Beautiful Bill Act, into law. The Company is currently in the process of analyzing the tax impacts of the law change. In accordance with GAAP, the Company will account for the tax effects of changes in tax law in the period of enactment which is the third quarter of calendar year 2025.

20

14. RELATED PARTY TRANSACTIONS

The Company defines related parties as directors, executive officers, nominees for director and stockholders that have significant influence over the Company, or are a greater than 10% beneficial owner of the Company’s capital and their affiliates or immediate family members. Transchip, an equity method investee of the Company, is also deemed as a related party.On November 15, 2024, the Company entered into a design services licensing collaboration agreement with Transchip. This arrangement gives Transchip a non-exclusive license right to make design house offerings using certain of the Company's products. The Company retains the manufacturing and royalty-related rights in relation to the Company’s products used in the design house offerings. During the three months ended March 31, 2025, the Company delivered a three-year term license to Transchip under this arrangement. During the three months ended June 30, 2025, the Company performed a reassessment of the agreement with Transchip in accordance with ASC 606, Revenue from Contracts with Customers. Specifically, the Company reevaluated whether a contract existed under step one of the five step approach, which requires that it is probable that the Company will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. As a result of this reassessment, the Company concluded that the criteria for the existence of the contract under ASC 606 were not met as of June 30, 2025. Consequently, the previously recognized amounts related to this arrangement were reversed. The reversal resulted